These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6548630)

  • 41. Low-energy red light radiation improves antitumor activity of cyclophosphamide.
    Sheiko EA; Shikhlyarova AI; Kurkina TA
    Bull Exp Biol Med; 2004 Dec; 138(6):590-2. PubMed ID: 16134821
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regulation of activity of cathepsins B, L, and D in murine lymphosarcoma model at a combined treatment with cyclophosphamide and yeast polysaccharide.
    Khalikova TA; Zhanaeva SY; Korolenko TA; Kaledin VI; Kogan G
    Cancer Lett; 2005 Jun; 223(1):77-83. PubMed ID: 15890239
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High dose cyclophosphamide plus recombinant human granulocyte-colony stimulating factor (rhG-CSF) in the treatment of follicular, low grade non-Hodgkin's lymphoma: CALGB 9150.
    Lichtman SM; Petroni G; Schilsky RL; Johnson JL; Perri RT; Niedzwiecki D; Sklar J; Barcos M; Peterson BA
    Leuk Lymphoma; 2001; 42(6):1255-64. PubMed ID: 11911406
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Advanced lymphosarcoma: intensive cyclical combination chemotherapy with cyclophosphamide, vincristine, and prednisone.
    Bagley CM; Devita VT; Berard CW; Canellos GP
    Ann Intern Med; 1972 Feb; 76(2):227-34. PubMed ID: 5066691
    [No Abstract]   [Full Text] [Related]  

  • 45. Combinatorial ribavirin and interferon alfacon-1 therapy of acute arenaviral disease in hamsters.
    Gowen BB; Smee DF; Wong MH; Pace AM; Jung KH; Bailey KW; Blatt LM; Sidwell RW
    Antivir Chem Chemother; 2006; 17(4):175-83. PubMed ID: 17066896
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Interferon in the treatment of multiple myeloma].
    Kuzmits R; Ludwig H; Cortelezzi A; Van Camp BG; Polli E; Flener R; Scheithauer W
    Acta Med Austriaca; 1985; 12(5):135-8. PubMed ID: 3914174
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antitumor effects of antibody-diphtheria toxin conjugates. III. Cyclophosphamide-induced immune unresponsiveness to conjugates.
    Moolten FL; Capparell NJ; Zajdel SH
    J Natl Cancer Inst; 1975 Sep; 55(3):709-12. PubMed ID: 51091
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A preclinical model for sequential high-dose chemotherapy.
    Holden SA; Teicher BA; Ayash LJ; Frei E
    Cancer Chemother Pharmacol; 1995; 36(1):61-4. PubMed ID: 7720177
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Method for testing mutagenic effects of chemicals on spermatogonia of the Chinese hamster: results obtained with cyclophosphamide, saccharin, and cyclamate.
    Machemer L; Lorke D
    Arzneimittelforschung; 1975; 25(12):1889-96. PubMed ID: 1243659
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enhancement of antiviral activity against hepatitis C virus in vitro by interferon combination therapy.
    Okuse C; Rinaudo JA; Farrar K; Wells F; Korba BE
    Antiviral Res; 2005 Jan; 65(1):23-34. PubMed ID: 15652968
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antigenic heterogeneity of metastasizing and nonmetastasizing forms of hamster lymphosarcoma: comparison of primary tumor and spontaneous liver metastases.
    Shah SA; Sherbet GV; Lakshmi MS; Wildridge M
    Invasion Metastasis; 1985; 5(5):245-54. PubMed ID: 3161845
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Clinical trial of a combination of human lymphoblastoid interferon (HLBI), melphalan and prednisolone (HLBI-MP) in multiple myeloma].
    Hara M; Nakamura T; Fujii Y
    Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1338-41. PubMed ID: 3579331
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oral melphalan pharmacokinetics: influence of interferon-induced fever.
    Ehrsson H; Eksborg S; Wallin I; Osterborg A; Mellstedt H
    Clin Pharmacol Ther; 1990 Jan; 47(1):86-90. PubMed ID: 2295223
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preclinical biology of alpha interferons.
    Trotta PP
    Semin Oncol; 1986 Sep; 13(3 Suppl 2):3-12. PubMed ID: 3532333
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chitotriosidase as a new marker of macrophage stimulation in a tumor model treated with cyclophosphamide and Ukrain.
    Korolenko TA; Djanayeva SJ; Falameyeva OV; Wevers RA; Filjushina EE; Buzueva II; Kaledin VI; Sandula J; Nowicky J
    Drugs Exp Clin Res; 2000; 26(5-6):279-83. PubMed ID: 11345039
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy and toxicity of doxorubicin/cyclophosphamide maintenance therapy in dogs with multicentric lymphosarcoma.
    Price GS; Page RL; Fischer BM; Levine JF; Gerig TM
    J Vet Intern Med; 1991; 5(5):259-62. PubMed ID: 1748977
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Alpha-2-interferon/melphalan/prednisone in previously untreated patients with multiple myeloma: a phase I-II trial.
    Cooper MR; Fefer A; Thompson J; Case DC; Kempf R; Sacher R; Neefe J; Bickers J; Scarffe JH; Spiegel R
    Cancer Treat Rep; 1986 Apr; 70(4):473-6. PubMed ID: 3698041
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antitumor activity of new anthracycline antibiotics, aclacinomycin-A and its analogs, and their toxicity.
    Hori S; Shirai M; Hirano S; Oki T; Inui T; Tsukagoshi S; Ishizuka M; Takeuchi T; Umezawa H
    Gan; 1977 Oct; 68(5):685-90. PubMed ID: 579346
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dose escalation of biweekly cyclophosphamide, doxorubicin, vincristine, and prednisolone using recombinant human granulocyte colony stimulating factor in non-Hodgkin's lymphoma.
    Tanosaki R; Okamoto S; Akatsuka N; Ishida A; Michikawa N; Masuda Y; Uchida H; Murata M; Kizaki M; Ikeda Y
    Cancer; 1994 Oct; 74(7):1939-44. PubMed ID: 7521788
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas.
    Schütt P; Passon J; Ebeling P; Welt A; Müller S; Metz K; Moritz T; Seeber S; Nowrousian MR
    Eur J Haematol; 2007 Feb; 78(2):93-101. PubMed ID: 17313557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.